Endotype-Targeted Therapy to Rescue OSA Patients Struggling With CPAP Adherence (TOP-CPAP)

NCT05951023 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Obstructive Sleep Apnea

Interventions

DRUG: Eszopiclone 2 mg
DRUG: Placebo

Sponsor

University of California, San Diego

Collaborators

[object Object]